Just in:
VinFast expands access to comprehensive aftersales network in France and Germany through agreement with Mobivia // Emirates Offer Support as Wildfires Ravage Greece // Qmiax Exchange: Shaping a New Future of Secure and Compliant Cryptocurrency Trading // Galaxy Macau Unveils the New Galaxy Kidz: An Edutainment Center for Play Time // A Feast Without Footprint – Shiok Kitchen Catering Redefines Delicious Dining with Carbon Neutral Catering // Innovative Study On Solvent Recycling In Warfare Published // Gunfire exchange near Manipur polling booth // UAE Delegation Engages in Arab Parliament Committee Discussions // Global Energy Leaders Chart Course for Sustainable Future at IRENA Assembly // NEOM welcomes leading industry figures and investors to Hong Kong showcase as part of its ‘Discover NEOM’ China tour // VT Markets Releases Study on Upcoming Bitcoin Halving and Market Implications // Abu Dhabi Environment Agency Endorses ADNOC’s Decarbonization Push // Takeoff After Turbulence: Flydubai Restarts Operations at Dubai International Airport // Congress Is Set To Perform Well In Lok Sabha Polls In Karnataka // Tech Giant Discharges Workers Following Disruptive Protest // AI Race Heats Up: Meta Unveils Powerful New Llama // Belt and Road Initiative Sees Robust Trade Growth in First Quarter // Get Based with Mr. Based: The Future of Community-Driven Cryptocurrency // Imperative of Action Against Dubious Kuki-Chin Armed Movement // The International Exhibition of Inventions in Geneva Reveals More than 40 Scientific and Technological Innovation Achievements from Hong Kong //

Trump considering Dr. Scott Gottlieb to head U.S. FDA

By Toni Clarke

ADVERTISEMENT

Dr. Scott Gottlieb, a partner at one of the world’s largest venture capital funds and a former deputy commissioner at the U.S. Food and Drug Administration, is being considered by President-elect Donald Trump to run the agency, according to sources close to the transition team. Gottlieb, 44, a venture partner at New Enterprise Associates and resident fellow at the American Enterprise Institute, a conservative think tank based in Washington, is well known in health policy circles and is a frequent commentator on television and in print.

Gottlieb is being considered alongside Jim O’Neill, a self-declared libertarian and colleague of Peter Thiel, the co-founder of Mithril Capital Management who was an early Trump supporter and is now advising his transition team. Bloomberg News first reported that Trump was looking at O’Neill.

Trump, a Republican, takes office on Jan. 20.

Michael Gaba, federal policy leader of law firm Holland & Knight’s national Healthcare & Life Sciences Team, said Gottlieb would be more palatable to more people than O’Neill, who believes drugs should be allowed on the market before their efficacy has been established, as long as they are safe.

Even the drug industry would likely oppose that stance, Gaba said, since companies want to be able to make credible claims that their products are effective in treating the diseases they say do.

“They want the FDA’s Good Housekeeping seal of approval,” Gaba said last week, adding, however, that drug makers would like to provide less data to get it.

Gottlieb would be a more traditional choice than O’Neill and fits the profile of what Trump’s administration seems to be looking for, he said.

“He leans right, he’s got experience in the agency, he’s got the M.D. credential, and he’s outspoken,” Gaba said.

The FDA historically has named someone with medical credentials to head the agency. O’Neill has none, though he served as principal associate deputy secretary of health and human services under the George W. Bush administration.

Gottlieb’s ties to the pharmaceutical industry run deep. He sits on the boards of multiple companies and advises others, including the British pharmaceutical giant GlaxoSmithKline Plc (GSK.L).

He is also a managing director of investment banking at T.R. Winston & Co, a Los Angeles-based, privately held investment bank that focuses on healthcare, clean energy and consumer technology.

According to its website, the firm provides services to a range of healthcare clients, “including companies engaged in the clinical development of new therapeutic compounds, drug discovery techniques, medical technologies, and devices.”

Between 2003 and 2004 Gottlieb was a senior adviser to the FDA commissioner and then the agency’s director of medical policy development. In 2004 he also acted as senior adviser to the Centers for Medicare and Medicaid Services.

From 2005-2007 he was the FDA’s deputy commissioner for medical and scientific affairs.

Gottlieb has a medical degree from Mount Sinai School of Medicine and a bachelor’s degree in economics from Wesleyan University. He advises the U.S. Department of Health and Human Services as a member of the Federal Health Information Technology Policy Committee.

(Reporting by Toni Clarke in Washington; Editing by Jonathan Oatis)

-Reuters

ADVERTISEMENT

ADVERTISEMENT
Just in:
Abu Dhabi Environment Agency Endorses ADNOC’s Decarbonization Push // Gunfire exchange near Manipur polling booth // AI Race Heats Up: Meta Unveils Powerful New Llama // Evolution and current state of global crypto adoption – Octa // NEOM welcomes leading industry figures and investors to Hong Kong showcase as part of its ‘Discover NEOM’ China tour // Galaxy Macau Unveils the New Galaxy Kidz: An Edutainment Center for Play Time // Global Energy Leaders Chart Course for Sustainable Future at IRENA Assembly // VT Markets Releases Study on Upcoming Bitcoin Halving and Market Implications // Takeoff After Turbulence: Flydubai Restarts Operations at Dubai International Airport // UAE Delegation Engages in Arab Parliament Committee Discussions // Sharjah Charity International Extends Helping Hand to Flood Victims // Navigating Business Setup in Dubai: A Comprehensive Guide by Czar Bizserv // Tech Giant Discharges Workers Following Disruptive Protest // Innovative Study On Solvent Recycling In Warfare Published // Imperative of Action Against Dubious Kuki-Chin Armed Movement // Belt and Road Initiative Sees Robust Trade Growth in First Quarter // Get Based with Mr. Based: The Future of Community-Driven Cryptocurrency // VinFast expands access to comprehensive aftersales network in France and Germany through agreement with Mobivia // Congress Is Set To Perform Well In Lok Sabha Polls In Karnataka // UN Acknowledges Uneven Progress on Energy Goals During Sustainability Week //